VERRICA PHARMACEUTICALS INC (VRCA)
US92511W1080 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to VRCA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 13.26. This target is 95.29% above the current price.
VRCA was analyzed by 12 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about VRCA.
In the previous month the buy percentage consensus was at a similar level.
VRCA was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-10 | Needham | Reiterate | Buy -> Buy |
| 2024-03-01 | Needham | Reiterate | Buy -> Buy |
| 2024-03-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-12-15 | Jefferies | Reiterate | Buy -> Buy |
| 2023-11-10 | Needham | Maintains | Buy -> Buy |
| 2023-10-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-23 | Needham | Reiterate | Buy -> Buy |
| 2023-08-10 | Needham | Reiterate | Buy -> Buy |
| 2023-07-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-07-25 | Needham | Upgrade | Hold -> Buy |
| 2023-07-25 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-07-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-22 | Jefferies | Initiate | Buy |
| 2023-03-07 | RBC Capital | Reiterate | Outperform |
| 2023-02-13 | RBC Capital | Upgrade | Sector Perform -> Outperform |
| 2022-05-31 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-25 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2022-03-10 | Brookline Capital | Initiate | Buy |
| 2022-03-03 | Needham | Maintains | Buy |
| 2021-09-22 | HC Wainwright & Co. | Maintains | Buy |
| 2021-09-21 | Needham | Maintains | Buy |
| 2021-09-21 | RBC Capital | Maintains | Outperform |
| 2021-05-14 | RBC Capital | Initiate | Outperform |
| 2021-03-08 | HC Wainwright & Co. | Maintains | Buy |
| 2021-02-17 | Needham | Maintains | Buy |